Compagnie Lombard Odier SCmA’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-12,000
| Closed | -$34K | – | 655 |
|
|
2017
Q4 | $34K | Buy |
12,000
+6,000
| +100% | +$17K | ﹤0.01% | 550 |
|
|
2017
Q3 | $27K | Hold |
6,000
| – | – | ﹤0.01% | 571 |
|
|
2017
Q2 | $28K | Sell |
6,000
-32,200
| -84% | -$150K | ﹤0.01% | 582 |
|
|
2017
Q1 | $161K | Sell |
38,200
-30,000
| -44% | -$126K | 0.01% | 387 |
|
|
2016
Q4 | $282K | Sell |
68,200
-4,000
| -6% | -$16.5K | 0.01% | 399 |
|
|
2016
Q3 | $584K | Hold |
72,200
| – | – | 0.02% | 334 |
|
|
2016
Q2 | $563K | Sell |
72,200
-8,000
| -10% | -$62.4K | 0.02% | 325 |
|
|
2016
Q1 | $620K | Hold |
80,200
| – | – | 0.02% | 316 |
|
|
2015
Q4 | $866K | Buy |
80,200
+7,000
| +10% | +$75.6K | 0.03% | 255 |
|
|
2015
Q3 | $506K | Sell |
73,200
-10,000
| -12% | -$69.1K | 0.02% | 273 |
|
|
2015
Q2 | $737K | Buy |
83,200
+77,200
| +1,287% | +$684K | 0.03% | 254 |
|
|
2015
Q1 | $59K | Hold |
6,000
| – | – | ﹤0.01% | 766 |
|
|
2014
Q4 | $73K | Hold |
6,000
| – | – | ﹤0.01% | 596 |
|
|
2014
Q3 | $60K | Buy |
+6,000
| New | +$60K | ﹤0.01% | 706 |
|